This is a research study evaluating the use of escitalopram (Lexapro®) for the treatment of major depression in subjects with temporal lobe epilepsy. The purpose of the study is to measure the severity and change in depressive and anxiety symptoms after 10 weeks of study treatment with escitalopram or placebo as measured by certain rating scales and questionnaires. In addition, the study will measure the frequency of seizures using a patient diary during the study. Finally, the study will assess the change in the quality of life using rating scales.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
8
10 mg daily for the first week followed by an increase to 20 mg daily for the remainder of the study
Placebo
LSU Anxiety and Mood Disorders Clinic
New Orleans, Louisiana, United States
Montgomery And Asberg Depression Rating Scale
Time frame: Screen, Baseline, Week 1, Week 2, Week 4, Week 6, Week 8 and Week 10
Clinician's Global Impression Severity and Improvement subscales
Time frame: Baseline, Week 1, Week 2, Week 4, Week 6, Week 8 and Week 10
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.